UPSTREAM BIO INC. - COMMON STOCK

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

12 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Upstream Bio to Present at Upcoming March Investor Conferences

25 Feb 2025 08:00:01 By Nasdaq GlobeNewswire

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 Jan 2025 08:00:01 By Nasdaq GlobeNewswire

Upstream Bio Appoints Allison Ambrose as General Counsel

17 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Upstream Bio Announces Addition to Russell 2000® Index

16 Dec 2024 08:00:04 By Nasdaq GlobeNewswire

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

21 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15 Oct 2024 16:15:00 By Nasdaq GlobeNewswire